Literature DB >> 8148678

Integrated care for asthma: a clinical, social, and economic evaluation. Grampian Asthma Study of Integrated Care (GRASSIC)

.   

Abstract

OBJECTIVES: To evaluate integrated care for asthma in clinical, social, and economic terms.
DESIGN: Pragmatic randomised trial.
SETTING: Hospital outpatient clinics and general practices throughout the north east of Scotland. PATIENTS: 712 adults attending hospital outpatient clinics with a diagnosis of asthma confirmed by a chest physician and pulmonary function reversibility of at least 20%. MAIN OUTCOME MEASURES: Use of bronchodilators and inhaled and oral steroids; number of general practice consultations and hospital admissions for asthma; sleep disturbance and other restrictions on normal activity; psychological aspects of health including perceived asthma control; patient satisfaction; and financial costs.
RESULTS: After one year there were no significant overall differences between those patients receiving integrated asthma care and those receiving conventional outpatient care for any clinical or psychosocial outcome. For pulmonary function, forced expiratory volume was 76% of predicted for integrated care patients and 75% for conventional outpatients (95% confidence interval for difference -3.6% to 5.0%). Patients who had experienced integrated care were more likely to select it as their preferred course of future management (75% (251/333) v 62% (207/333) (6% to 20%)); they saved 39.52 pounds a year. This was largely because patients in conventional outpatient care consulted their general practitioner as many times as those in integrated care, who were not also visiting hospital.
CONCLUSION: Integrated care for moderately severe asthma patients is clinically as effective as conventional outpatient care, cost effective, and an attractive management option for patients, general practitioners, and hospital consultants.

Entities:  

Mesh:

Year:  1994        PMID: 8148678      PMCID: PMC2539573     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Asthma--still a challenge for general practice.

Authors:  K Jones
Journal:  J R Coll Gen Pract       Date:  1989-06

2.  Increased rates of illness and death from asthma in Canada.

Authors:  Y Mao; R Semenciw; H Morrison; L MacWilliam; J Davies; D Wigle
Journal:  CMAJ       Date:  1987-10-01       Impact factor: 8.262

3.  Tuberculous meningitis in children.

Authors: 
Journal:  Br Med J       Date:  1971-01-02

4.  Asthma mortality in England and Wales: evidence for a further increase, 1974-84.

Authors:  P G Burney
Journal:  Lancet       Date:  1986-08-09       Impact factor: 79.321

5.  Problems of comprehensive shared diabetes care.

Authors:  J L Day; H Humphreys; H Alban-Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-20

6.  Prevalence of asthma and hay fever in England and Wales.

Authors:  D M Fleming; D L Crombie
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-31

7.  Randomised controlled trial of routine hospital clinic care versus routine general practice care for type II diabetics.

Authors:  T M Hayes; J Harries
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-22

8.  The "Asthma Self-Efficacy Scale".

Authors:  D L Tobin; J K Wigal; J A Winder; K A Holroyd; T L Creer
Journal:  Ann Allergy       Date:  1987-10

9.  Computer assisted shared care in hypertension.

Authors:  J C Petrie; O J Robb; J Webster; A K Scott; T A Jeffers; M D Park
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-29

10.  Evaluation of the need for follow-up in an out-patient clinic.

Authors:  A G Leitch; S Parker; A Currie; T King; G J McHardy
Journal:  Respir Med       Date:  1990-03       Impact factor: 3.415

View more
  19 in total

Review 1.  Issues at the interface between primary and secondary care in the management of common respiratory disease. 3: Providing better asthma care: what is there left to do?

Authors:  R G Neville; B G Higgins
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  The limited incorporation of economic analyses in clinical practice guidelines.

Authors:  Joel F Wallace; Scott R Weingarten; Chiun-Fang Chiou; James M Henning; Andriana A Hohlbauch; Margaret S Richards; Nicole S Herzog; Lior S Lewensztain; Joshua J Ofman
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

Review 3.  The economics of shared care packages.

Authors:  S M McGhee; A J Hedley
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

4.  Identification of asthmatic children using prescription data and diagnosis.

Authors:  Grete Moth; Peter Vedsted; Po Schiøtz
Journal:  Eur J Clin Pharmacol       Date:  2007-03-27       Impact factor: 2.953

5.  Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study.

Authors:  J G Williams; W Y Cheung; I T Russell; D R Cohen; M Longo; B Lervy
Journal:  BMJ       Date:  2000-02-26

6.  Organisation of asthma care: what difference does it make? A systematic review of the literature.

Authors:  A J Eastwood; T A Sheldon
Journal:  Qual Health Care       Date:  1996-09

Review 7.  Primary care based clinics for asthma.

Authors:  Elora Baishnab; Charlotta Karner
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

8.  Effectiveness of routine self monitoring of peak flow in patients with asthma. Grampian Asthma Study of Integrated Care (GRASSIC).

Authors: 
Journal:  BMJ       Date:  1994-02-26

Review 9.  Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports.

Authors:  Scott R Weingarten; James M Henning; Enkhe Badamgarav; Kevin Knight; Vic Hasselblad; Anacleto Gano; Joshua J Ofman
Journal:  BMJ       Date:  2002-10-26

10.  General practitioners with a special clinical interest: a model for improving respiratory disease management.

Authors:  Siân Williams; Dermot Ryan; David Price; Carol Langley; Monica Fletcher; Paul Everden
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.